Author

Tammy Macartney

Institution: AbbVie (Germany)

Observed institutions: AbbVie (United States), AbbVie (Germany)

OpenAlex ID: A5037501663

Targeting BCL ‐2 with venetoclax and dexamethasone in patients with relapsed/refractory t(11;14) multiple myeloma

2020 · Jonathan L. Kaufman, Cristina Gasparetto, et al. · American Journal of Hematology · 109

Phase I/II Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Dexamethasone As Targeted Therapy for Patients with t(11;14) Relapsed/Refractory Multiple Myeloma

2019 · Jonathan L. Kaufman, Cristina Gasparetto, et al. · Blood · 19

Works count: 2

Citation count: 128

H-index: 2

I10-index: 2